CV Sciences, Inc. (CVSI)

↓ Download CSV

CIK 0001510964 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, CV Sciences, Inc. reported revenue of $13.79M, down 12.2% from the prior year. The company ran a net loss, with a net margin of -6.9% and a gross margin of 49.0%. It held $6.96M in total assets against $5.49M in total liabilities.

Key ratios (FY2025)

49.0%
Gross margin
-3.4%
Operating margin
-6.9%
Net margin
-65.3%
Return on equity
-12.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$13.79M$15.71M$16.00M$16.20M$20.05M$24.43M$53.70M
Cost of Revenue$7.04M$8.54M$8.92M$10.65M$11.43M$13.42M$18.61M$14.37M$6.19M$4.06M
Gross Profit$6.75M$7.17M$7.08M$5.55M$8.62M$11.01M$35.09M$33.88M$14.49M$7.00M
Operating Income-$470.0K-$2.19M$3.36M-$6.85M-$18.45M-$22.59M-$17.24M$10.25M-$4.86M-$13.07M
Net Income-$958.0K-$2.39M$3.10M-$8.21M-$15.55M-$22.28M-$16.61M$10.00M-$4.90M-$14.14M
EPS (Diluted)$-0.01$-0.01$0.02$-0.07$-0.14$-0.22$-0.17$0.11$-0.06
Total Assets$6.96M$7.93M$9.20M$12.74M$18.07M$30.62M$52.69M$36.90M$22.71M$18.59M
Total Liabilities$5.49M$6.13M$6.30M$13.51M$14.52M$19.41M$23.54M$6.79M$6.33M$5.38M
Shareholders' Equity$1.47M$1.79M$2.90M-$777.0K$3.54M$11.21M$29.15M$30.12M$16.38M$13.21M
Cash & Equivalents$611.0K$1.38M$4.02M$9.11M$12.68M
Operating Cash Flow-$407.0K-$861.0K$2.25M-$1.89M-$7.49M-$7.30M-$2.23M$12.56M$3.62M-$2.05M
Capital Expenditures$109.0K$18.0K$0$0$35.0K$1.06M$1.15M$893.0K$454.0K$17.2K
Shares Outstanding184.26M184.26M161.68M152.10M112.48M100.66M99.42M94.94M90.51M57.62M